The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR–ABL- and JAK2V617F-Positive MPN
Authors:
- Stefan TillmannSTStefan Tillmann
- Kathrin OlschokKOKathrin Olschok
- Sarah K. SchröderSarah K. Schröder
- Marlena BütowMBMarlena Bütow
- Julian BaumeisterJBJulian Baumeister
- Milena KalmerMKMilena Kalmer
- Vera PreußgerVPVera Preußger
- Barbora WeinbergerovaBWBarbora Weinbergerova
- Kim KricheldorfKKKim Kricheldorf
- Jiri MayerJMJiri Mayer
- Blanka KubesovaBKBlanka Kubesova
- Zdenek RacilZRZdenek Racil
Open Access
Abstract
Lipocalin 2 (LCN2), a proinflammatory mediator, is involved in the pathogenesis of myeloproliferative neoplasms (MPN). Here, we investigated the molecular mechanisms of LCN2 overexpression in MPN. LCN2 mRNA expression was 20-fold upregulated in peripheral blood (PB) mononuclear cells of chronic myeloid leukemia (CML) and myelofibrosis (MF) patients vs. healthy controls. In addition, LCN2 serum levels were significantly increased in polycythemia vera (PV) and MF and positively correlated with JAK2V617F and mutated CALR allele burden and neutrophil counts. Mechanistically, we identified endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) as a main driver of LCN2 expression in BCR-ABL- and JAK2V617F-positive 32D cells. The UPR inducer thapsigargin increased LCN2 expression >100-fold, and this was not affected by kinase inhibition of BCR-ABL or JAK2V617F. Interestingly, inhibition of the UPR regulators inositol-requiring enzyme 1 (IRE1) and c-Jun N-terminal kinase (JNK) significantly reduced thapsigargin-induced LCN2 RNA and protein expression, and luciferase promoter assays identified nuclear factor kappa B (NF-κB) and CCAAT binding protein (C/EBP) as critical regulators of mLCN2 transcription. In conclusion, the IRE1–JNK-NF-κB–C/EBP axis is a major driver of LCN2 expression in MPN, and targeting UPR and LCN2 may represent a promising novel therapeutic approach in MPN.Keywords
Funding Information
- IZKF of the Faculty of Medicine RWTH Aachen (O3-1)
- Deutsche Forschungsgemeinschaft (DFG KO 2155/6-1, DFG KO 2155/7-1, DFG CH 1509/1-1)
- José Carreras Leukämie-Stiftung (DJCLS 16R/2017)
This publication has 46 references indexed in Scilit:
- STAT1, NF-κB and ERKs play a role in the induction of lipocalin-2 expression in adipocytesMolecular Metabolism, 2013
- The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cellsCell Cycle, 2012
- Molecular Mechanism Underlying Persistent Induction of LCN2 by Lipopolysaccharide in Kidney FibroblastsPLOS ONE, 2012
- ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent mannerBMC Cancer, 2011
- The Unfolded Protein Response, Degradation from the Endoplasmic Reticulum, and CancerGenes & Cancer, 2010
- Lipocalin 2 is required for BCR-ABL-induced tumorigenesisOncogene, 2008
- Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemiaLeukemia & Lymphoma, 2008
- Inflammation and cancerNature, 2002
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitroGenes & Development, 1999